Dr. Peter Valk (Erasmus MC) presents the molecular MRD technique and explains how and why this technique is used in AML treatment. He discusses CBF gen fusions, MRD monitoring in mutant NPM1 AML with RQ-PCR, next generation sequencing (NGS) and the ELN guidelines. At the end of the video there is a discussion with Prof. Dr. Jacqueline Cloos (Amsterdam UMC) about the pros and cons of using molecular MRD in AML.
Intended for: practitioners Why: up-to-date knowledge When: watch now Language: Dutch with French subtitles Duration: 12 minutes